戻る Agenda
Session 1: Drug Development: An Overview
Session Chair(s)
Dana Bell
United States
Nancy Pire Smerkanich, DrSc, MS
Assistant Professor Regulatory & Quality Sciences
University of Southern California School of Pharmacy, United States
Michael Hamrell, PhD, RAC
President
MORIAH Consultants, United States
- Regulation Highlights
- Key Definitions
- Drug Development Highlights
- Regulatory Strategy